MD News (press release)Early PET Predicts Survival Outcomes in B-Cell LymphomaMD News (press release)An interim [ 18 F] fluorodeoxyglucose positron emission tomography can effectively predict the survival outcomes of patients with diffuse large B-cell …
Early PET Predicts Survival Outcomes in B-Cell Lymphoma – Doctors Lounge
MD NewsEarly PET Predicts Survival Outcomes in B-Cell LymphomaDoctors LoungeAn interim [ 18 F] fluorodeoxyglucose positron emission tomography can effectively predict the survival outcomes of patients with diffuse large B-cell lymphoma after two cycles…
REVLIMID(R) Evaluated in Combination with Rituximab as a Potential Treatment … – MarketWatch (press release)
REVLIMID(R) Evaluated in Combination with Rituximab as a Potential Treatment …MarketWatch (press release)The multicenter phase II study enrolled 69 patients and evaluated the efficacy and safety of combination therapy with lenalidomide and rituximab …
Major cause of chronic kidney disease-related inflammation is identified – HealthCanal.com
AsiaOneMajor cause of chronic kidney disease-related inflammation is identifiedHealthCanal.comUC Irvine researchers have uncovered an important source of inflammation seen in people with chronic kidney disease, which is increasingly common due to the e…
Organ donor Alison gave the gift of life to others – Enniscorthy Guardian
Organ donor Alison gave the gift of life to othersEnniscorthy GuardianTHE tragic death of a woman after she fell down stairs gave the gift of life to several others as she was an organ donor, Wexford Coroner's Court has heard. The inquest into the …
ASH: Obinutuzumab Bests Rituximab in Patients With Relapsed Non-Hodgkin Lymphoma – Cancer Network
ASH: Obinutuzumab Bests Rituximab in Patients With Relapsed Non-Hodgkin LymphomaCancer NetworkSAN DIEGO—Obinutuzumab (GA101) achieved higher response rates than rituximab in the first head-to-head trial of the two biologic agents in patients with rel…
Agent discovery could protect against atherosclerosis – Barchester Healthcare
Agent discovery could protect against atherosclerosisBarchester HealthcareBone marrow transplantation experiments also indicated that A2bAR bone marrow cell signals alone were not sufficient to elicit this effect. A2bAR is an anti-inflammatory and has …
BiovaxID(R) Lymphoma Vaccine-Induced T-Cell Immune Responses Complement … – MarketWatch (press release)
BiovaxID(R) Lymphoma Vaccine-Induced T-Cell Immune Responses Complement …MarketWatch (press release)The results (detailed in Abstract #2707), reported by a Senior Investigator from the NCI, demonstrated that vaccination with BiovaxID active immunothe…
HIV drug reduces graft-versus-host disease in stem cell transplant patients … – EurekAlert (press release)
HIV drug reduces graft-versus-host disease in stem cell transplant patients …EurekAlert (press release)(SAN DIEGO) — An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease …
Abbott Labs Spinoff Looks Like the Right Move – Investorplace.com
Abbott Labs Spinoff Looks Like the Right MoveInvestorplace.comAlso in development is daclizumab, which appears to be both safe and effective in treating the most common form of multiple sclerosis. Phase III testing is also underway for bardoxolone, whi…